 |
|
|
 |
Enrollment begins for osteoarthritis initiative
Recruitment has begun for the Osteoarthritis Initiative (OAI), a public-private partnership between the National Institutes of Health and industry that funds a multisite contract to create a resource to hasten discovery of biological markers for osteoarthritis (OA).
more
|
|
Health Canada advises Canadians under the age of 18 to consult physicians if they are being treated with newer anti-depressants
Health Canada is advising Canadians that patients under 18 who are currently being treated with a newer anti-depressant -- Selective Serotonin Re-uptake Inhibitors (SSRIs) or Serotonin Noradrenaline Re-uptake Inhibitors (SNRIs) -- should consult their treating physician to confirm that the benefits of the drug still outweigh its potential risks in light of recent safety concerns. more
|
|
Drug resistant tuberculosis levels ten times higher in Eastern Europe and Central Asia
Tuberculosis patients in parts of Eastern Europe and Central Asia are 10 times more likely to have multidrug-resistant TB (MDR-TB) than in the rest of the world, according to a World Health Organization (WHO) report into the deadly infectious disease. China, Ecuador, Israel and South Africa are also identified as key areas. more
|
|
|
|
Blood test heralds speedy stroke diagnoses
A quick and cheap blood test could soon help doctors tell if a patient is having a stroke and help them get the right treatment as soon as possible. Future versions might even be able to distinguish between different kinds of strokes.
more
|
|
Smallpox vaccine may cause both serious and benign skin rashes
People who have never received a smallpox vaccination may develop any of a variety of benign skin rashes a few days after getting vaccinated for smallpox that should not be confused with a more serious complication of the vaccine, according to an article in the April 1 issue of Clinical Infectious Diseases, now available online. more
|
|
Combination therapy drives cancer into remission
Researchers have achieved an experimental breakthrough in the simultaneous use of two or more agents for treating cancer, known as combination therapy. If it is shown to be safe and effective in humans, the therapy outlined by the new study is a promising general strategy for treating many cancers that do not respond to current therapies. more
|
|
FDA and the U.S. Attorney for the Western District of Texas announce guilty plea in drug counterfeiting case
The Food and Drug Administration and the U.S. Attorney for the Western District of Texas announced today that Hadi M. Ghandour, owner of Genapharm, Inc. of Austin, Texas, pled guilty on March 9, 2004 to four counts of an indictment charging conspiracy to introduce misbranded and unapproved new drugs into interstate commerce, counterfeiting human growth hormone, and possessing controlled drugs with intent to distribute. more
|
|
|
